Retraction

Polymyxin B, Cefoperazone Sodium-Sulbactam Sodium, and Tigecycline against Multidrug-Resistant Acinetobacter baumannii Pneumonia

Paper Information

Record ID:
59539
Publication Date:
May 31, 2022
Retraction Date:
December 13, 2023 (1.9 year years ago)
Article Type:
Publisher:
Hindawi
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:

Citations (2)

2
Total Citations
0
Post-Retraction
1
Pre-Retraction
0
Same Day
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Retracted: Polymyxin B, Cefoperazone Sodium‐Sulbactam Sodium, and Tigecycline against Multidrug‐Resistant <i>Acinetobacter baumannii</i> Pneumonia
Evidence-Based Complementary and Alternative Medicine
Evidence-based Complementary and Alternative Medicine Open Access
Published: Jan 2023
346 days before retraction
Quick Stats
Total Citations: 2
Years Since Retraction: 1.9 year
Open Access: Yes
Last Checked: Jul 24, 2025
Related Papers
Synergistic Effect of Zuo Jin Wan on DDP-Induced Apoptosis …
Evidence-Based Complementary and Alternative Medicine • 13 citations
Severe disseminated infection by hypermucoviscous Klebsiell…
Journal of Infection and Chemotherapy • 0 citations
Citrus Genus and Its Waste Utilization: A Review on Health-…
Evidence-Based Complementary and Alternative Medicine • 94 citations
The Therapeutic Potential of Wogonin Observed in Preclinica…
Evidence-Based Complementary and Alternative Medicine • 47 citations
Noscapine, an Emerging Medication for Different Diseases: A…
Evidence-Based Complementary and Alternative Medicine • 47 citations